IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GRISANTI, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.153
AS - Asia 4.146
EU - Europa 3.127
SA - Sud America 953
AF - Africa 109
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.991
SG - Singapore 1.662
CN - Cina 1.109
BR - Brasile 792
IT - Italia 557
HK - Hong Kong 506
DE - Germania 457
UA - Ucraina 444
PL - Polonia 403
FI - Finlandia 314
VN - Vietnam 263
RU - Federazione Russa 225
GB - Regno Unito 186
TR - Turchia 161
IE - Irlanda 133
FR - Francia 100
CA - Canada 94
IN - India 93
AR - Argentina 64
SE - Svezia 64
ID - Indonesia 61
CZ - Repubblica Ceca 56
BD - Bangladesh 54
JP - Giappone 46
ZA - Sudafrica 46
NL - Olanda 42
MX - Messico 40
IQ - Iraq 33
AT - Austria 32
BE - Belgio 26
EC - Ecuador 25
PK - Pakistan 25
ES - Italia 22
UZ - Uzbekistan 18
AE - Emirati Arabi Uniti 17
SA - Arabia Saudita 16
CO - Colombia 14
MA - Marocco 14
PY - Paraguay 12
CL - Cile 11
EG - Egitto 11
LT - Lituania 11
PE - Perù 11
VE - Venezuela 11
AZ - Azerbaigian 10
CH - Svizzera 9
DZ - Algeria 9
GR - Grecia 9
PT - Portogallo 9
JO - Giordania 8
IL - Israele 7
JM - Giamaica 7
LB - Libano 7
AU - Australia 6
KE - Kenya 6
TW - Taiwan 6
UY - Uruguay 6
AL - Albania 5
CR - Costa Rica 5
ET - Etiopia 5
IR - Iran 5
KZ - Kazakistan 5
LY - Libia 5
PA - Panama 5
CY - Cipro 4
KG - Kirghizistan 4
LV - Lettonia 4
MU - Mauritius 4
PH - Filippine 4
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EU - Europa 3
GY - Guiana 3
KR - Corea 3
LK - Sri Lanka 3
NP - Nepal 3
RO - Romania 3
TH - Thailandia 3
HN - Honduras 2
NO - Norvegia 2
OM - Oman 2
TG - Togo 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
CM - Camerun 1
FK - Isole Falkland (Malvinas) 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 16.488
Salva come PNG Salva come JPEG
Città #
Ashburn 768
Singapore 759
Fairfield 746
Woodbridge 532
Hong Kong 496
Warsaw 398
Houston 397
Dallas 326
Seattle 313
Jacksonville 309
Cambridge 305
Chandler 301
Beijing 291
Wilmington 266
Los Angeles 263
Chicago 258
New York 257
Princeton 178
Helsinki 174
Ann Arbor 166
Munich 141
Istanbul 131
The Dalles 123
Salt Lake City 107
Dublin 101
Buffalo 98
Ho Chi Minh City 94
Moscow 90
Nanjing 87
Brescia 83
Turku 78
São Paulo 75
Boardman 72
Shanghai 69
Redondo Beach 66
Des Moines 58
Secaucus 55
San Francisco 54
Tampa 52
Dearborn 50
Elk Grove Village 50
Jakarta 50
Hanoi 47
Milan 45
Brno 42
Lancaster 42
London 38
Changsha 37
Nanchang 37
Brooklyn 35
San Diego 35
Santa Clara 33
Dong Ket 32
Nuremberg 31
Washington 30
Dalmine 29
Romola 29
Rio de Janeiro 28
Sterling 28
Montreal 27
Shenyang 27
Stockholm 27
Brussels 26
Poplar 26
West Jordan 26
Lappeenranta 24
Tianjin 24
Tokyo 24
Belo Horizonte 23
Boston 23
Menlo Park 22
Phoenix 22
Jinan 21
Johannesburg 21
Toronto 21
Chennai 20
Denver 20
Vienna 20
Atlanta 19
Naples 19
Guangzhou 18
Tashkent 17
Zhengzhou 17
Ankara 16
Dulles 16
Hebei 16
Orem 16
Curitiba 15
Charlotte 14
Düsseldorf 14
Frankfurt am Main 14
Hangzhou 14
Verona 13
Amsterdam 12
Buenos Aires 12
Kunming 12
New Delhi 12
Olomouc 12
Turin 12
Vignate 12
Totale 10.651
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 762
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 359
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 231
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 223
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 223
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 220
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 204
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 202
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 195
Immunotherapy failure in adrenocortical cancer: where next? 194
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 192
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 192
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 190
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 187
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 184
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 184
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 181
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 174
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 169
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 165
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 164
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 160
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 159
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 158
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 156
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 155
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 155
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 152
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 151
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 151
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 151
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 146
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 143
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 143
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 143
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 142
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 138
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 137
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 137
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 135
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 135
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 133
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 132
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 130
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 128
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 128
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 126
An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial 124
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 121
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 119
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 118
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 118
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 117
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 117
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 114
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 111
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 110
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 110
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 109
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 107
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. 103
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 102
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 101
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 101
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 100
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 99
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 97
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 96
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 94
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial 93
Comparison of the prognostic classification with recursive partitioning analysis (RPA) and general prognostic assessment (GPA) in a retrospective analysis of 430 patients with brain metastases 91
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 91
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 91
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 91
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 91
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma 90
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli 88
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 88
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 87
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 87
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 86
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 84
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 82
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 82
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 80
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 80
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 80
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 80
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 79
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 79
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors 78
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 78
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 78
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 77
Needs in breast cancer patients (pts) during chemotherapy: Customer satisfaction evaluation 77
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 76
TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma 76
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 75
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 75
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 73
Totale 13.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.000 0 0 0 0 0 173 52 171 150 214 123 117
2021/2022848 67 82 30 96 22 53 36 56 43 108 64 191
2022/2023823 106 53 42 63 70 191 5 74 119 22 44 34
2023/20241.474 71 41 133 93 104 269 46 79 226 69 49 294
2024/20254.477 50 47 62 557 406 297 276 151 457 288 1.014 872
2025/20264.297 667 1.045 733 955 793 104 0 0 0 0 0 0
Totale 16.811